Spots Global Cancer Trial Database for palonosetron hydrochloride
Every month we try and update this database with for palonosetron hydrochloride cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Palonosetron Hydrochloride in Preventing Nausea and Vomiting Caused by Radiation Therapy in Patients With Primary Abdominal Cancer | NCT00903396 | Anal Cancer Carcinoma of th... Colorectal Canc... Extrahepatic Bi... Gallbladder Can... Gastric Cancer Gastrointestina... Liver Cancer Nausea and Vomi... Pancreatic Canc... Primary Periton... Small Intestine... | palonosetron hy... placebo | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Netupitant and Palonosetron Hydrochloride in Preventing Chronic Nausea and Vomiting in Patients With Cancer | NCT03040726 | Malignant Neopl... Nausea Vomiting | Netupitant Palonosetron Palonosetron Hy... Placebo Questionnaire A... | 18 Years - | M.D. Anderson Cancer Center | |
| Ondansetron Versus Palonosetron Antiemetic Regimen Prior to Highly Emetogenic Chemotherapy(HEC) | NCT01640340 | Malignant Neopl... | aprepitant palonosetron hy... ondansetron dexamethasone | 18 Years - 88 Years | Ohio State University Comprehensive Cancer Center | |
| Palonosetron and Dexamethasone With or Without Dronabinol in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy For Cancer | NCT00553059 | Chemotherapy-in... Unspecified Adu... | dexamethasone dronabinol palonosetron hy... placebo | 18 Years - | M.D. Anderson Cancer Center | |
| Ondansetron Versus Palonosetron Antiemetic Regimen Prior to Highly Emetogenic Chemotherapy(HEC) | NCT01640340 | Malignant Neopl... | aprepitant palonosetron hy... ondansetron dexamethasone | 18 Years - 88 Years | Ohio State University Comprehensive Cancer Center | |
| Efficacy and Safety of Palonosetron Hydrochloride in the Prevention of Nausea and Vomiting | NCT01481831 | Neoplasms Chemotherapy-In... | Palonosetron Hy... Palonosetron Hy... | 18 Years - 75 Years | Shanghai Changzheng Hospital | |
| Netupitant and Palonosetron Hydrochloride in Preventing Chemotherapy Induced Nausea and Vomiting in Patients With Cancer Undergoing BEAM Conditioning Regimen Before Stem Cell Transplant | NCT03097588 | Malignant Neopl... | Netupitant Palonosetron Hy... Questionnaire A... | 18 Years - | OHSU Knight Cancer Institute | |
| Ondansetron Versus Palonosetron Antiemetic Regimen Prior to Highly Emetogenic Chemotherapy(HEC) | NCT01640340 | Malignant Neopl... | aprepitant palonosetron hy... ondansetron dexamethasone | 18 Years - 88 Years | Ohio State University Comprehensive Cancer Center | |
| APF530 or Aloxi (Palonosetron Hydrochloride) Combined With Dexamethasone in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy for Cancer | NCT00343460 | Nausea and Vomi... Unspecified Adu... | APF530 dexamethasone Palonosetron Hy... placebo | 18 Years - 120 Years | Heron Therapeutics | |
| Phase II Trial of Aprepitant & Palonosetron for CINV Prevention w FOLFOX | NCT00381862 | Colorectal Canc... Nausea and Vomi... | aprepitant dexamethasone fluorouracil irinotecan hydr... leucovorin calc... oxaliplatin palonosetron hy... quality-of-life... | 18 Years - 120 Years | OHSU Knight Cancer Institute | |
| Protreat-Trial: Prophylactic Antiemetic Treatment of Opioid-induced Nausea and Vomiting (OINV) in Palliative Care | NCT05315999 | Nausea Vomiting Pain Advanced Cancer | Palonosetron Hy... Placebo | 18 Years - | University Hospital Freiburg | |
| Prevention of Delayed Nausea A Phase III Double-Blind Placebo-Controlled Clinical Trial | NCT00475085 | Nausea | aprepitant dexamethasone granisetron hyd... palonosetron hy... prochlorperazin... placebo | 18 Years - | University of Rochester | |
| Fosaprepitant Dimeglumine, Palonosetron Hydrochloride, and Dexamethasone in Preventing Nausea and Vomiting Caused by Cisplatin in Patients With Stage III or Stage IV Head and Neck Cancer Undergoing Chemotherapy and Radiation Therapy | NCT00895245 | Nausea and Vomi... Stage III Squam... Stage III Squam... Stage III Squam... Stage III Squam... Stage III Squam... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... | fosaprepitant d... cisplatin palonosetron hy... dexamethasone Functional Livi... Emesis Diary Radiotherapy | 18 Years - 70 Years | University of Washington |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
